| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MARKSANS PHARMA LTD. (BSE: 524404)
524404 Technical Analysis
5
| As on 24th Dec 2024 524404 SHARE Price closed @ 293.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 143.70 & Strong Buy for SHORT-TERM with Stoploss of 164.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
524404SHARE Price
| Open | 294.00 | Change | Price | % |
| High | 299.50 | 1 Day | 0.10 | 0.03 |
| Low | 292.55 | 1 Week | 105.75 | 56.28 |
| Close | 293.65 | 1 Month | 105.75 | 56.28 |
| Volume | 59976 | 1 Year | 133.80 | 83.70 |
| 52 Week High 299.50 | 52 Week Low 126.05 | ||||
BSE INDIA Most Active Stocks
| 532822 | 7.47 | -0.13% |
| 532411 | 0.41 | 0.00% |
| 517001 | 0.09 | 12.50% |
| 511700 | 1.01 | -0.98% |
| 512149 | 0.88 | 0.00% |
| 511389 | 7.25 | -2.42% |
| 534690 | 7.65 | 4.79% |
| 532775 | 2.04 | -0.97% |
| 531328 | 1.05 | 0.96% |
| 532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 524404 Daily Charts |
524404 Intraday Charts |
Whats New @ Bazaartrend |
524404 Free Analysis |
|
|
524404 Important Levels Intraday
| RESISTANCE | 307.04 |
| RESISTANCE | 302.75 |
| RESISTANCE | 300.09 |
| RESISTANCE | 297.44 |
| SUPPORT | 289.86 |
| SUPPORT | 287.21 |
| SUPPORT | 284.55 |
| SUPPORT | 280.26 |
524404 Target April 2025
| 4th UP Target | 0 |
| 3rd UP Target | 0 |
| 2nd UP Target | 0 |
| 1st UP Target | 0 |
| 1st DOWN Target | 0 |
| 2nd DOWN Target | 0 |
| 3rd DOWN Target | 0 |
| 4th DOWN Target | 0 |
524404 Weekly Target
| 4th UP Target | 0.00 |
| 3rd UP Target | 0.00 |
| 2nd UP Target | 0.00 |
| 1st UP Target | 0.00 |
| 1st DOWN Target | 0.00 |
| 2nd DOWN Target | 0.00 |
| 3rd DOWN Target | 0.00 |
| 4th DOWN Target | 0.00 |
524404 Target2025
| 4th UP Target | 380.72 |
| 3rd UP Target | 310.21 |
| 2nd UP Target | 266.62 |
| 1st UP Target | 223.03 |
| 1st DOWN Target | 98.67 |
| 2nd DOWN Target | 55.08 |
| 3rd DOWN Target | 11.49 |
| 4th DOWN Target | -59.02 |
MARKSANS PHARMA LTD. ( BSE INDIA Symbol : 524404 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
524404 Business Profile
Marksans Pharma Limited, together with its subsidiaries, researches, develops, manufactures, markets, distributes, and sells generic pharmaceutical formulations in North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the analgesic, anti-inflammatory, benign prostatic hyperplasia, epilepsy, hyperparathyroidism, diabetic and antidiabetic, pain management, neurology, antacid, hormonal, antifungal, antiulcerative, cardiovascular and central nervous system, vitamin, cough and cold, dermatology, gastrointestinal, gynecology, cephalosporin, injectable, antibacterial, hypertension, oncology, and antibiotics and anti-allergic therapeutic areas. It also provides contract research and manufacturing services; and develops and out-licenses patented products. The company was incorporated in 1992 and is headquartered in Mumbai, India. Address: Grandeur, Mumbai, India, 400053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service